MEDTOX Scientific, Inc.  

(Public, NASDAQ:MTOX)   Watch this stock  
Find more results for MTOX
0.0000
Real-time:  
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 0.55
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 4.14% 4.12%
Operating margin 6.28% 6.63%
EBITD margin - 12.34%
Return on average assets 6.24% 5.85%
Return on average equity 8.18% 7.97%
Employees 667 -
CDP Score - -

Address

402 West County Road D
ST. PAUL, MN 55112
United States - Map
+1-302-6365400 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

MEDTOX Scientific, Inc. (MEDTOX) operates through its wholly owned subsidiaries, MEDTOX Laboratories, Inc. (MEDTOX Laboratories), MEDTOX Diagnostics, Inc. (MEDTOX Diagnostics) and New Brighton Business Center, LLC (NBBC). MEDTOX Laboratories provides forensic and clinical laboratory services. MEDTOX Diagnostics manufactures and distributes diagnostic devices and other similar products. During the year ended December 31, 2011, MEDTOX Laboratories and MEDTOX Diagnostics accounted for 79% and 21% of the Company�s revenues, respectively. The Company operates in two segments: Laboratory Services, which consists of the activities conducted by MEDTOX Laboratories and NBBC, and Product Sales conducted by MEDTOX Diagnostics. During the year ended December 31, 2011, the Company introduced its EZ-Screen Cup product. The EZ-Screen Cup is targeted for the government, corporate and occupational health clinic markets. On July 31, 2012, Laboratory Corporation of America Holdings acquired MEDTOX.